| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | 1 | +$8.0K | Bought Jul 10, 26 | |
| Josh Gottheimer NJ05 | 1 | −$8.0K | Trimmed Apr 9, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Jul 10, 26 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Sep 4, 26 (56d) | |
| Apr 9, 25 | Josh Gottheimer NJ05 | Joint | Sell (part) | $1,001 - $15,000 | May 14, 25 (35d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 10, 2026 | Bengtsson Carl MartinChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 8.3K | — |
| Feb 10, 2026 | Reid Martin LutherOfficer | Stock Award(Grant) at price 0.00 per share. | 3.3K | — |
| Feb 10, 2026 | Tignor Michael BrentOfficer | Stock Award(Grant) at price 0.00 per share. | 3.1K | — |
| Feb 10, 2026 | Van Gunsteren Job LeonardOfficer | Stock Award(Grant) at price 0.00 per share. | 1.8K | — |
| Feb 10, 2026 | Vicente MonicaDirector | Stock Award(Grant) at price 0.00 per share. | 870 | — |
| Feb 10, 2026 | Miyata HatsukiOfficer | Stock Award(Grant) at price 0.00 per share. | 4K | — |
| Feb 10, 2026 | Boned FredericOfficer | Stock Award(Grant) at price 0.00 per share. | 5.1K | — |
| Feb 10, 2026 | Rigaud OlivierDirector | Stock Award(Grant) at price 0.00 per share. | 870 | — |
| Feb 10, 2026 | Graham GeorgeOfficer | Stock Award(Grant) at price 0.00 per share. | 700 | — |
| Feb 10, 2026 | Fischer David BDirector | Stock Award(Grant) at price 0.00 per share. | 870 | — |
| Feb 10, 2026 | Harris Theodore LChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 25.6K | — |
| Feb 10, 2026 | Backus William AOfficer | Stock Award(Grant) at price 0.00 per share. | 2.2K | — |
| Feb 10, 2026 | Fish Kathleen BDirector | Stock Award(Grant) at price 0.00 per share. | 870 | — |
| Feb 10, 2026 | Wineinger Matthew DavidDirector | Stock Award(Grant) at price 0.00 per share. | 870 | — |
| Feb 10, 2026 | Knutson Daniel E.Director | Stock Award(Grant) at price 0.00 per share. | 870 | — |
| Dec 3, 2025 | Van Gunsteren Job LeonardOfficer | Conversion of Exercise of derivative security at price 60.85 per share. | 6K | $365.10K |
| Dec 3, 2025 | Van Gunsteren Job LeonardOfficer | Sale at price 153.07 - 153.80 per share. | 6K | $919.72K |
| Dec 2, 2025 | Fischer David BDirector | Conversion of Exercise of derivative security at price 74.57 - 84.09 per share. | 6K | $472.33K |
| Dec 2, 2025 | Fischer David BDirector | Sale at price 153.91 - 154.15 per share. | 8K | $1.23M |
| Nov 10, 2025 | Reid Martin LutherOfficer | Sale at price 154.44 per share. | 1.2K | $185.33K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 11.0 | 6.6 | -6.6 | -4.6 | -3.0 | 7.8 | -0.8 | 5.0 | -6.2 | 2.0 | +9.7% | ||
| 2025 | -1.9 | 8.8 | -4.6 | -5.7 | 6.5 | -4.5 | -4.2 | 6.3 | -7.4 | 2.2 | 1.8 | -1.8 | −5.9% |
| 2024 | -5.8 | 12.2 | -1.4 | -8.8 | 8.6 | 0.2 | 15.3 | -0.2 | -0.6 | -4.9 | 7.9 | -9.7 | +9.6% |
| 2023 | 7.0 | -0.5 | -2.7 | 3.9 | -5.9 | 9.0 | -0.1 | 4.3 | -11.7 | -6.3 | 7.3 | 19.3 | +21.8% |
| 2022 | -12.8 | -5.9 | -1.2 | -9.9 | 1.0 | 4.3 | 4.6 | -2.9 | -7.8 | 15.0 | 0.7 | -13.3 | −27.6% |
| 2021 | -7.1 | 11.5 | 5.1 | 1.4 | 3.0 | 0.2 | 2.8 | 4.1 | 3.3 | 5.5 | 3.2 | 6.7 | +46.3% |
| 2020 | 6.3 | -12.6 | 4.5 | -9.6 | 12.8 | -5.8 | 5.7 | -2.6 | -0.1 | 2.4 | 3.7 | 11.1 | +13.4% |
| 2019 | 6.0 | 6.9 | 4.6 | 9.4 | -10.7 | 10.2 | 2.7 | -13.5 | 11.7 | 2.0 | -1.6 | 2.0 | +29.7% |
| 2018 | -2.0 | -4.7 | 8.6 | 7.9 | 9.3 | 1.8 | 2.2 | 10.6 | 1.1 | -16.5 | -7.4 | -9.6 | −2.8% |
| 2017 | 1.6 | 2.3 | -5.4 | -1.5 | -3.0 | -1.3 | -0.1 | -3.4 | 8.4 | 3.7 | 3.5 | -7.6 | −4.0% |
| 2016 | -7.7 | 12.7 | -2.0 | -1.1 | -2.3 | -0.5 | 7.1 | 9.6 | 10.7 | -2.1 | 5.2 | 5.1 | +38.0% |
| 2015 | -20.5 | 11.2 | -6.0 | -5.3 | 7.7 | -1.3 | 1.7 | 3.3 | 3.8 | 12.4 | 0.3 | -11.2 | −8.8% |
| 2014 | -7.1 | -7.4 | 3.2 | 18.9 | -11.0 | -2.9 | -6.6 | 2.9 | 10.0 | 14.4 | 0.5 | 2.5 | +13.5% |
| 2013 | 2.6 | 7.8 | 9.0 | -1.4 | 10.8 | -6.8 | 11.2 | -3.8 | 8.1 | 10.6 | 3.3 | -0.8 | +61.0% |
| 2012 | -6.7 | -28.0 | 11.0 | -4.5 | 0.5 | 12.3 | 2.2 | 9.5 | 0.7 | -5.2 | 2.6 | 2.0 | −10.1% |
| 2011 | -0.5 | 7.0 | 4.2 | 5.8 | 8.7 | 1.5 | -0.0 | -5.6 | -9.7 | -1.2 | 12.6 | -2.3 | +19.9% |
| 2010 | -13.2 | 13.0 | 12.5 | 5.2 | -6.4 | 2.9 | 5.8 | -7.6 | 26.2 | -1.0 | 1.3 | 9.2 | +51.3% |
| 2009 | -10.4 | -7.1 | 21.1 | -1.0 | -3.2 | 1.7 | 13.2 | -10.3 | 5.6 | 4.9 | 15.5 | 5.1 | +34.5% |
| 2008 | -8.1 | -2.6 | 14.4 | -0.3 | 8.1 | -6.4 | 9.2 | 8.1 | -2.3 | -4.2 | 1.8 | -4.3 | +11.3% |
| 2007 | -10.3 | -3.5 | 19.4 | 4.0 | -4.0 | 3.0 | -6.4 | 20.8 | -0.6 | 6.4 | -1.5 | 4.7 | +30.7% |
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Buy / hold / sell counts